218 related articles for article (PubMed ID: 37461351)
1. Folate-mediated Transport of Nanoparticles across the Placenta.
Kalashnikova I; Patrikeeva S; Nanovskaya TN; Andreev YA; Ahmed MS; Rytting E
Pharm Nanotechnol; 2024; 12(2):171-183. PubMed ID: 37461351
[TBL] [Abstract][Full Text] [Related]
2. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
[TBL] [Abstract][Full Text] [Related]
3. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of lutein loaded folate conjugated polymeric nanoparticles.
Bolla PK; Gote V; Singh M; Yellepeddi VK; Patel M; Pal D; Gong X; Sambalingam D; Renukuntla J
J Microencapsul; 2020 Nov; 37(7):502-516. PubMed ID: 32842813
[TBL] [Abstract][Full Text] [Related]
5. Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
Li YJ; Dong M; Kong FM; Zhou JP
Int J Pharm; 2015 Jul; 489(1-2):83-90. PubMed ID: 25888801
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
[TBL] [Abstract][Full Text] [Related]
7. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
[TBL] [Abstract][Full Text] [Related]
8. Uptake and transport of pullulan acetate nanoparticles in the BeWo b30 placental barrier cell model.
Tang H; Jiang Z; He H; Li X; Hu H; Zhang N; Dai Y; Zhou Z
Int J Nanomedicine; 2018; 13():4073-4082. PubMed ID: 30034233
[TBL] [Abstract][Full Text] [Related]
9. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
10. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
Chen J; Li S; Shen Q; He H; Zhang Y
Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
[TBL] [Abstract][Full Text] [Related]
12. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
[TBL] [Abstract][Full Text] [Related]
13. Folic acid-decorated PEGylated magnetite nanoparticles as efficient drug carriers to tumor cells overexpressing folic acid receptor.
Movileanu C; Anghelache M; Turtoi M; Voicu G; Neacsu IA; Ficai D; Trusca R; Oprea O; Ficai A; Andronescu E; Calin M
Int J Pharm; 2022 Sep; 625():122064. PubMed ID: 35952802
[TBL] [Abstract][Full Text] [Related]
14. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
[TBL] [Abstract][Full Text] [Related]
15. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.
Esmaeili F; Ghahremani MH; Ostad SN; Atyabi F; Seyedabadi M; Malekshahi MR; Amini M; Dinarvand R
J Drug Target; 2008 Jun; 16(5):415-23. PubMed ID: 18569286
[TBL] [Abstract][Full Text] [Related]
16. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
17. In vitro placental model optimization for nanoparticle transport studies.
Cartwright L; Poulsen MS; Nielsen HM; Pojana G; Knudsen LE; Saunders M; Rytting E
Int J Nanomedicine; 2012; 7():497-510. PubMed ID: 22334780
[TBL] [Abstract][Full Text] [Related]
18. Dual tumor-targeted poly(lactic-
Chen J; Wu Q; Luo L; Wang Y; Zhong Y; Dai HB; Sun D; Luo ML; Wu W; Wang GX
Int J Nanomedicine; 2017; 12():5745-5760. PubMed ID: 28848351
[TBL] [Abstract][Full Text] [Related]
19. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery.
Xin Y; Liu T; Yang C
Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]